New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biopharmaceutical Bioseparation Systems Industry" - https://www.reportlinker.com/p03646060/?utm_source=GNW
Biological agents like biological membranes, enzymes and plants are used for large-scale purification of biological products based on engineering and scientific principles. Depending upon the various characteristics, such as volatility, solubility, density, size, electrostatic charge, diffusivity, shape, polarity, and electrostatic charge, the biological products are separated as well as purified using a bioseparation technique. Increasing demand for biological pharmaceuticals, emergence of new biologics such as vaccines and monoclonal antibodies, and advent of biosimilars or generic biological drugs are driving the production of these drugs, in turn driving the demand for bioseparation systems used in their manufacturing.
Bioprocessing represents an expensive, complex and time-consuming step in the production of biopharmaceutical drugs. Designing downstream processing presents significant challenges, as characterizing the identity and structure as well as measuring targeted components is innately difficult. Development of biological drugs takes several years leaving limited time on market for these drugs to gain returns on investments. Consequently, there is a growing emphasis on evolution of technologies in this area to reduce expenses and make them more efficient.
Amid the COVID-19 crisis, the global market for Biopharmaceutical Bioseparation Systems estimated at US$8.5 Billion in the year 2020, is projected to reach a revised size of US$14 Billion by 2026, growing at a CAGR of 8.6% over the analysis period. Chromatography, one of the segments analyzed in the report, is projected to grow at a 8.1% CAGR to reach US$7.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Technologies segment is readjusted to a revised 9.1% CAGR for the next 7-year period. This segment currently accounts for a 47.8% share of the global Biopharmaceutical Bioseparation Systems market.
The U.S. Market is Estimated at $4.1 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026
The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$4.1 Billion in the year 2021. The country currently accounts for a 44.67% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 11% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR while Rest of European market (as defined in the study) will reach US$1.6 Billion by the close of the analysis period.
The market is forecast to grow rapidly in the imminent future, driven by the continuous modification of traditional separation methods, as well as availability of new technologies. Chromatography systems, centrifuges, membrane/filters, and other forms of bioseparation systems are used for separation of biological products, such as biopharmaceuticals. Factors such as growing biopharmaceuticals demand, technological advancements in terms of equipment, and government initiatives aimed at increasing awareness are propelling growth in the global bioseparation systems market. Additionally, the growing use of single-use/disposable instruments spurred by slew of regulations and increasing focus on production efficiency and product quality are driving growth in the market. An example is the disposable continuous chromatography. Such single-use systems are designed to be more precise and enable more accurate analysis of data. Furthermore, the new and more efficient systems are also cost effective in addition to being reliable and featuring better functionalities.
The development of advanced therapeutics is also creating a favorable scenario for demand growth of separation systems. Developments, such as HBs-AG generated by heterologous-expression in yeasts, the first-of-its-kind inhalable insulin powder meant for diabetics, and such others are expected to drive further market growth. Research is also ongoing for the development of recombinant-fusion protein markers targeting infectious diseases. Researchers are trying to identify the impact of host-cell protein in the production of recombinant protein and are also focused on identification and characterization of cold-active enzymes, which have significant potential for several commercial applications, particularly food processing. These and many such innovations that are currently underway are expected to present significant growth opportunities for the bioseparation market in the coming years. Furthermore, growing demand for cell-based therapies and personalized medicines would also create strong demand for bioseparation techniques in the years ahead. These factors would result in increased adoption of novel technology-based bioseparation systems for large scale downstream-processing.
Select Competitors (Total 52 Featured)
- 3M Purification Inc.
- Agilent Technologies, Inc.
- Alfa Wassermann Separation Technologies LLC
- Flottweg Separation Technology
- GE Healthcare Life Sciences
- GEA Westfalia Separator Group GmbH
- KNAUER Wissenschaftliche Geräte GmbH
- Konik Nanobiotech SL
- Merck KGaA
- Pall Corporation
- ProMetic Life Sciences Inc.
- Repligen Corp.
- Sartorius Stedim Biotech
- Thermo Fischer Scientific Inc.
- Tosoh Bioscience Inc.
- YMC Europe GMBH
Read the full report: https://www.reportlinker.com/p03646060/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
The Race Between the Virus & Vaccines Intensifies. Amidst this
Chaotic Battle, Where is the World Economy Headed in 2021?
EXHIBIT 1: How Fast the World is Vaccinated Will Determine How
Soon the Pandemic Will End: Global Number of Annual COVID-19
Vaccine Doses (In Million) for Years 2020 through 2025 by
Geographic Region/Country
Progress on Vaccinations, Why Should Businesses Care?
These are Times When Questions Abound & Answers Are Few
With IMF?s Upward Revision of Global GDP Forecasts for 2021,
Most Companies Are Bullish About a Global Economic Comeback.
EXHIBIT 2: A Strong 2021 Economic Rebound Based On Pent-Up
Demand Comes as a Relief for Suffering Industries & Markets:
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
How the Healthcare Industry Has & Continues to be Impacted by
the Pandemic & What?s the New Normal?
EXHIBIT 3: With the COVID-19 Pandemic Exposing Global
Healthcare Unpreparedness, There is Increasing Policy Led
Focus on Rebooting Health Systems Worldwide: Current &
Required Healthcare Spending as % of GDP
Impact of COVID-19 on Bioseparation Market
Scope of Affinity Chromatography in Aiding the Vaccine
Purification methodology
A Prelude to Biopharmaceutical Bioseparation Systems
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products - An Overview
Bioseparation Systems - Invaluable Tools in Biopharmaceutical
Manufacturing
US Remains Market Leader; Developing Countries to Drive Market
Growth
Chromatography Leads the Pack
Competition
EXHIBIT 4: Leading Players in the Global Biopharmaceutical
Bioseparation Systems Market (2020): Percentage Market Share
Breakdown of Revenues
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Biopharmaceutical Market Drives Demand for
Bioseparation Systems
EXHIBIT 5: Top 10 Biopharmaceutical Companies: 2019
Biological License Application (BLA) Approvals-2021
Biological License Application (BLA) Approvals-2020
Biological License Application (BLA) Approvals: 2019
Growing Biosimilars Market - A Clear Advantage for
Bioseparation Technologies
Patent Expiries of Major Biopharmaceutical Drugs in the US and
Europe
Progressive Regulatory Framework Accelerates Product Approvals &
Subsequently Market Revenues
Specific Guidelines for Biosimilars in Various Countries with
Year of Publication
Biosimilars Regulatory Agencies in Select Regional Markets
Biosimilar Approvals in the US (as of February 2021)
Biosimilar Approvals in Europe (as of January 2021)
High Demand for Monoclonal Antibodies Generates Significant
Opportunities for Bioseparation Systems
Downstream Processing - A Major Trend among Biopharmaceutical
Manufacturers
Chromatography - The Gold Standard Separation Technology
EXHIBIT 6: Global Chromatography Market (2020): Percentage
Share Breakdown of Value Sales by Chromatography Techniques
for Gas Chromatography, Liquid Chromatography, Supercritical
Fluid Chromatography, Thin Layer Chromatography, and Others
Increasing Demand for Gas Chromatography in Biopharma Separation
Superior Efficiency Drives Use of Synthetic Ligands in Affinity
Chromatography
A Comparison of Protein and Synthetic Ligands
Pre-packed Disposable Columns in Chromatography Gain Attention
SMBC - An Old Approach Gaining Significant Attention
Major Advantages and Disadvantages of SMBC
Twin-Column SMB - An Emerging Alternative to Protein A Columns
Growing Focus on Alternatives to Protein A Chromatography
Chiral Chromatography Increases in Popularity
Chromatography Efficiency and Selectivity
Mixed-Mode Chromatography
Multimode Chromatography
Mixed-Mode and Multimode Media Offer Cost Savings
Flexible and Selective Chromatography Improves
Biopharmaceutical Efficiencies
Inherent Benefits of Membrane Chromatography to Drive its Use
in Bioprocessing
His-tagged purification of protein & Immobilized Metal Affinity
Chromatography (IMAC)
Growing Use of Membrane Filtration in Biopharmaceutical
Manufacturing
Downstream Production of Biopharmaceuticals: Filtration Challenges
Evolving Membrane Functions in Filtration for the Production of
mAbs
Filtration Technology: The Future
Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream
Purification
Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
Membrane & Bioseparation
Hand-powered Centrifuge setup can Diagnose Covid-19 for just a
dollar a test
Cell Disruption & Methods Gain Popularity
Advent of Innovative Technologies Streamline and Enhance
Production of Biopharmaceutical Systems
Introduction of Integrated Continuous Bioprocessing System
Improves Productivity and Minimizes Raw Material Wastage
Use of Continuous Processing Technique for Manufacturing Life-
Saving Medicines Gains Momentum
Demand for Sustainable Nanofiber Chromatography Mechanism
Witnesses an Upward Momentum
Use of Precipitation Technique for Purifying Therapeutic
Proteins Exhibits a Surge
Continuous Bioseparation Gains Momentum
Single-Use Systems Play a Key Role
Minimizing Centrifugation Steps
Single-Use Disposable Technologies Gain Attention
Increase in Healthcare Spending Stirs Demand for
Biopharmaceutical Bioseperation Systems
EXHIBIT 7: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
Growing Preference for Personalized Medicine to Drive Market
Growth
EXHIBIT 8: Global Personalized Medicine Market: Revenues in US$
Million for the Years 2019, 2021, 2023 and 2025
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Million for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Biopharmaceutical
Bioseparation Systems by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Million for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Geographic Region - Percentage
Breakdown of Value Revenues for USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets for Years 2012, 2021 & 2027
Table 4: World Current & Future Analysis for Chromatography by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Chromatography by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 6: World 15-Year Perspective for Chromatography by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 7: World Current & Future Analysis for Other Technologies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 10: USA Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 11: USA Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 12: USA 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
CANADA
Table 13: Canada Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 14: Canada Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 15: Canada 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
JAPAN
Table 16: Japan Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 17: Japan Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 18: Japan 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
CHINA
Table 19: China Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 20: China Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 21: China 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
EUROPE
Table 22: Europe Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Revenues in US$
Million for Years 2020 through 2027 and % CAGR
Table 23: Europe Historic Review for Biopharmaceutical
Bioseparation Systems by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2012 through 2019 and % CAGR
Table 24: Europe 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Geographic Region - Percentage
Breakdown of Value Revenues for France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets for Years 2012, 2021 &
2027
Table 25: Europe Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 26: Europe Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 27: Europe 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
FRANCE
Table 28: France Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 29: France Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 30: France 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
GERMANY
Table 31: Germany Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 32: Germany Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 33: Germany 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
ITALY
Table 34: Italy Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 35: Italy Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 36: Italy 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
UNITED KINGDOM
Table 37: UK Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 38: UK Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 39: UK 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
SPAIN
Table 40: Spain Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 41: Spain Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 42: Spain 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
RUSSIA
Table 43: Russia Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 44: Russia Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 45: Russia 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
REST OF EUROPE
Table 46: Rest of Europe Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 47: Rest of Europe Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 48: Rest of Europe 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Technology -
Percentage Breakdown of Value Revenues for Chromatography and
Other Technologies for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Table 49: Asia-Pacific Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR
Table 50: Asia-Pacific Historic Review for Biopharmaceutical
Bioseparation Systems by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Revenues in US$ Million for Years 2012
through 2019 and % CAGR
Table 51: Asia-Pacific 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Geographic Region -
Percentage Breakdown of Value Revenues for Australia, India,
South Korea and Rest of Asia-Pacific Markets for Years 2012,
2021 & 2027
Table 52: Asia-Pacific Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 53: Asia-Pacific Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 54: Asia-Pacific 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Technology -
Percentage Breakdown of Value Revenues for Chromatography and
Other Technologies for the Years 2012, 2021 & 2027
AUSTRALIA
Table 55: Australia Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 56: Australia Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 57: Australia 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
INDIA
Table 58: India Current & Future Analysis for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies - Independent Analysis of Annual Revenues in US$
Million for the Years 2020 through 2027 and % CAGR
Table 59: India Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 60: India 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
SOUTH KOREA
Table 61: South Korea Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 62: South Korea Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 63: South Korea 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 65: Rest of Asia-Pacific Historic Review for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies Markets - Independent
Analysis of Annual Revenues in US$ Million for Years 2012
through 2019 and % CAGR
Table 66: Rest of Asia-Pacific 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Technology -
Percentage Breakdown of Value Revenues for Chromatography and
Other Technologies for the Years 2012, 2021 & 2027
LATIN AMERICA
Table 67: Latin America Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Geographic Region -
Argentina, Brazil, Mexico and Rest of Latin America Markets -
Independent Analysis of Annual Revenues in US$ Million for
Years 2020 through 2027 and % CAGR
Table 68: Latin America Historic Review for Biopharmaceutical
Bioseparation Systems by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Revenues in US$ Million for Years 2012 through 2019
and % CAGR
Table 69: Latin America 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Geographic Region -
Percentage Breakdown of Value Revenues for Argentina, Brazil,
Mexico and Rest of Latin America Markets for Years 2012, 2021 &
2027
Table 70: Latin America Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 71: Latin America Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 72: Latin America 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Technology -
Percentage Breakdown of Value Revenues for Chromatography and
Other Technologies for the Years 2012, 2021 & 2027
ARGENTINA
Table 73: Argentina Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 74: Argentina Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 75: Argentina 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
BRAZIL
Table 76: Brazil Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 77: Brazil Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 78: Brazil 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
MEXICO
Table 79: Mexico Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 80: Mexico Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 81: Mexico 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Table 82: Rest of Latin America Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 83: Rest of Latin America Historic Review for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies Markets - Independent
Analysis of Annual Revenues in US$ Million for Years 2012
through 2019 and % CAGR
Table 84: Rest of Latin America 15-Year Perspective for
Biopharmaceutical Bioseparation Systems by Technology -
Percentage Breakdown of Value Revenues for Chromatography and
Other Technologies for the Years 2012, 2021 & 2027
MIDDLE EAST
Table 85: Middle East Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 86: Middle East Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 87: Middle East 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
AFRICA
Table 88: Africa Current & Future Analysis for
Biopharmaceutical Bioseparation Systems by Technology -
Chromatography and Other Technologies - Independent Analysis of
Annual Revenues in US$ Million for the Years 2020 through 2027
and % CAGR
Table 89: Africa Historic Review for Biopharmaceutical
Bioseparation Systems by Technology - Chromatography and Other
Technologies Markets - Independent Analysis of Annual Revenues
in US$ Million for Years 2012 through 2019 and % CAGR
Table 90: Africa 15-Year Perspective for Biopharmaceutical
Bioseparation Systems by Technology - Percentage Breakdown of
Value Revenues for Chromatography and Other Technologies for
the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 52
Read the full report: https://www.reportlinker.com/p03646060/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
